Navigation Links
Genesis Biopharma Announces Proposed Public Offering of Common Stock and Warrants
Date:4/9/2012

LOS ANGELES, April 9, 2012 /PRNewswire/ -- Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company developing targeted cancer immunotherapies, announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering.  The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. 

Oppenheimer & Co. Inc. and Roth Capital Partners, LLC are acting as joint book-running managers for the offering.  BTIG, LLC is acting as co-manager for the offering.

Genesis Biopharma intends to use the net proceeds of the offering to repay outstanding debt obligations, to fund research and development activities, and for general corporate purposes.

The securities described above are being offered by Genesis Biopharma pursuant to a shelf registration statement on Form S-3, including a base prospectus, previously filed with, and declared effective by, the Securities and Exchange Commission (SEC).  The securities may be offered only by means of a prospectus.  A preliminary prospectus supplement related to the offering has been filed with the SEC and will be available on the SEC's website located at www.sec.gov. Electronic copies of the preliminary prospectus supplement and the base prospectus relating to the offering may be obtained, when available, from Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 300 Madison Avenue, 5th Floor, New York, NY, 10017, by telephone at (212) 667-8563, or via email at EquityProspectus@opco.com and from Roth Capital Partners, LLC, Equity Capital Markets, 888 San Clemente Drive, Newport Beach, CA 92660, by telephone at (800) 678-9147, or via email at Rothecm@ro
'/>"/>

SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ValGenesis Suite 2.5 Certified by SAP as Powered by SAP NetWeaver®
2. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
3. ThermoGenesis Announces Approval of AXP® by India Ministry of Health
4. ThermoGenesis Announces Acceptance of AXP® Submission by Regulatory Body in China
5. Genesis Biosciences Announces New Hire and Promotions on Operational and Scientific Staff
6. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2011 on September 12, 2011
7. Genesis Biopharma Signs Cooperative Research and Development Agreement With the National Cancer Institute to Develop Cancer Immunotherapies
8. Genesis Biopharma Names Former Member of the Joint Chiefs of Staff General Merrill McPeak to Board of Directors
9. Genesis Biopharma Names David Voyticky to Board of Directors
10. Genesis Biopharma Director William H. Andrews, Ph.D., Profiled in Popular Science Feature Story
11. Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013  regulated information — Global ... Klauk today announced the launch of a new ... ones. The Pledge empowers the ... stand and make a personal commitment to demand more: ... health care team and additional partial-onset seizure control.  More ...
(Date:6/18/2013)... 18, 2013 The "Bioinformatics Market By Sector ... Management Tools & Data Analysis Services) & Application (Genomics, Proteomics ... Major Market Drivers, Restraints, and Opportunities in North ... Asia-Pacific and Rest of World. Browse ... 22 Figures 364 Pages ...
(Date:6/18/2013)... This webinar will examine the history ... and review the basic FDA regulations and guiding ... these principles through real world case studies and ... on FDA regulations and guidance related to prescription ... traditional and newer forms of promotional materials for ...
(Date:6/18/2013)... , June 18, 2013   Lexicon ... a biopharmaceutical company focused on discovering breakthrough treatments ... Northcott has joined the company as its ... Mr. Northcott brings extensive commercial experience to Lexicon, ... a variety of therapeutic areas. Mr. ...
Breaking Biology Technology:Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3
... U.S. HIV/AIDS Patients Live in States Now Providing ... Medicaid Coverage ... ,Monogram Biosciences, Inc. (Nasdaq: MGRM ) today announced that ... a diagnostic used to determine patient candidacy for Pfizer,s new,HIV ...
... or drop of liquid and the shape of the surface ... formula published this week in Physical Review Letters. , ... for a number of areas, including the chemical industry and ... explain how the relationship between the liquid and the surface ...
... in Europe ... expertise., BOSTON, April 7, 2008 The company is ... based in the United,Kingdom. Penny will work closely with US ... European and global,business. Penny specializes in the provision of actionable ...
Cached Biology Technology:New York Medicaid Program Establishes Coverage for Trofile(TM) 2New York Medicaid Program Establishes Coverage for Trofile(TM) 3New York Medicaid Program Establishes Coverage for Trofile(TM) 4Physicists saved from drowning in complexities of wetting theory 2Observant LLC Appoints Two New Directors to the Senior Management Team 2
(Date:6/18/2013)... hacker lab. At Brandeis University, sophisticated computational models ... scientists understand the complex interplay between genomic data, ... outer "shell" critical for replication. ... are finding will help researchers alter virus assembly, ... Jason Perlmutter, first author of the scientific paper ...
(Date:6/18/2013)... Joshua Obar, Ph.D., Department of Immunology and Infectious Diseases, ... ICAAC Young Investigator Award for his research on factors ... infection. , Obar earned his B.A. in Microbiology ... to complete his Ph.D. in Microbiology and Immunology from ... thesis research in Edward Usherwood,s laboratory at the Geisel ...
(Date:6/18/2013)... of DNA and this modification can occur in ... now, scientists believed that this epigenetic phenomenon actively ... team of researchers from the University of Geneva ... at the Faculty of Medicine, reveals that this ... methylation may play both a passive and active ...
Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2The American Society for Microbiology honors Joshua Obar 2The secret of DNA methylation 2
... 20th century and its link to race is the focus of ... Associate Professor Stephen Pemberton, PhD, an expert on the history of ... at the National Institutes of Health (NIH), Bethesda, 100th anniversary symposium ... B. Herrick. The event will be webcast. For more, ...
... of the Gulf oil spill, the possible risks of ... of an endangered fish in the Colorado River are ... Journalism Awards. The awards, administered by the American ... inception in 1945, go to professional journalists for distinguished ...
... a foreign object such as a catheter enters the body, ... a slick coating a biofilm that is highly ... be defeated by a basic approach of conventional means. Instead ... the key players in the network and how they operate. ...
Cached Biology News:Sickle cell disease and its link to race focus of NJIT researcher at NIH event 2Winners of 2010 AAAS Kavli Science Journalism Awards 2Winners of 2010 AAAS Kavli Science Journalism Awards 3Winners of 2010 AAAS Kavli Science Journalism Awards 4Winners of 2010 AAAS Kavli Science Journalism Awards 5Winners of 2010 AAAS Kavli Science Journalism Awards 6Winners of 2010 AAAS Kavli Science Journalism Awards 7Winners of 2010 AAAS Kavli Science Journalism Awards 8Research provides new leads in the case against drug-resistant biofilms 2
... The MyCycler thermal cycler system is used ... This system includes the MyCycler personal thermal ... for use with 0.2 ml tubes or ... and both algorithm and block modes of ...
... arrays have been developed for affinity ... A variety of ProteinChip chemical surfaces ... to their unique biochemical properties. Each ... side-by-side sample comparison, and the chips ...
... Pro system with colony-picking capabilities, 110-120 V, ... DNA, proteins, oligonucleotides, carbohydrates, lipids, and other ... microarray applications. This system can also be ... 300 micrometers in diameter and for inoculating ...
Freeze 'N Squeeze DNA gel extraction spin columns use a quick freeze-and-thaw cycle and centrifugation to draw 50-23,000 bp DNA out of agarose gel slices. Supplied as 25 columns....
Biology Products: